02-05-2025 17:56 via drugs.com

No Benefit Seen for Revascularization Added to Drug Therapy in Carotid Stenosis

FRIDAY, May 2, 2025-- For patients with asymptomatic or symptomatic carotid stenosis of 50 percent or greater with a low or intermediate predicted stroke risk, there is no benefit for the addition of revascularization to optimized medical therapy...
Read more »

Pharmaceutical news



Body Mass Index (BMI): What It Tells You — And What It Doesn’t
What You Should Know About ALS, Also Known as Lou Gehrig’s Disease
HHS, NIH Unveil Vaccine Initiative to Protect Against Future Pandemics
Withdrawal of Flovent Led to Discontinuation of Inhaled Steroids for Children With Asthma
Advanced Biological Age Linked to Increased Risk for Incident Dementia
Gluten-Free Diet for Celiac Disease Increases Arsenic Exposure in Children
Urinary Incontinence Linked to CVD Risk Factors, Comorbid Conditions
Buprenorphine for Opioid Use Disorder in Pregnancy Can Improve Outcomes
Semaglutide Beneficial in Metabolic Dysfunction-Associated Steatohepatitis, Fibrosis
Exposure to Smoke Pollution Ups Risk for Hospitalization for Respiratory Disease
RFK Jr. to Change Vaccine Testing Rules
More Than 1.8 Million Ninja Pressure Cookers Recalled for Burn Risk
Medetomidine, a Pet Sedative, Spreads in U.S. Illegal Drug Supply
Common Diabetes Drug Effective Against Knee Arthritis Pain
Desktop versie